Skip to content

Feasibility and Safety Analysis of Transurethral Retrograde Ureteral Stenting Under Disposable Electronic Cystoscope

Feasibility and Safety Analysis of Transurethral Retrograde Ureteral Stenting Under Disposable Electronic Cystoscope

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071869
Enrollment
Unknown
Registered
2023-05-26
Start date
2023-05-31
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ureteral obstruction

Interventions

Group of patients requiring retrograde ureteral stenting:Transurethral retrograde placement of a ureteral stent guided by a disposable bladder endoscope

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 18 Years

Inclusion criteria

Inclusion criteria: Only subjects who meet all of the following inclusion criteria are eligible for enrollment in this study: 1. Patients requiring retrograde ureteral stenting based on clinical indications. 2. Age = 18 years, regardless of gender. 3. Patients who voluntarily agree to participate in the study and provide signed informed consent.

Exclusion criteria

Exclusion criteria: Subjects who meet any of the following exclusion criteria will be excluded from this study: 1. Patients with severe urethral stricture that prevents dilation of the urethra and hinders the insertion of the bladder endoscope, making examination impossible. 2. Patients with a small bladder capacity, such as less than 50ml, where tuberculous bladder contraction is an absolute contraindication. 3. Patients with acute inflammation of the genitourinary system, such as acute cystitis, urethritis, prostatitis, or epididymitis. 4. Patients with uncorrected systemic hemorrhagic disorders. 5. Patients with severe hematuria that significantly interferes with the observation using the bladder endoscope. 6. Patients with other serious conditions who cannot tolerate bladder endoscopy surgery, as determined by the investigator, and are deemed unsuitable for participation in this study (excluding skeletal deformities or cases with difficult stone removal). 7. Patients with incomplete data or poor compliance. 8. Any medical or other conditions that the investigator deems may affect the clinical trial.

Design outcomes

Primary

MeasureTime frame
Successful completion of retrograde ureteral stenting;

Secondary

MeasureTime frame
Duration of the surgical procedure;Overall satisfaction level with the surgical procedure;Image clarity of the video monitor;Performance of active bending capability;Maneuverability;Difficulty of insertion into the urinary tract;Overall patient comfort;Intraoperative pain score;Incidence of postoperative complications;

Countries

China

Contacts

Public ContactXin Chen

Beijing Hospital, No. 1 Dahua Road, Dongcheng District, Beijing, China

chenxin5631@126.com+86 186 0040 5631

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026